Adicet to Present Preclinical Data from Allogeneic Gamma Delta T Cell Platform at SITC 36th Annual Meeting
Details of the poster presentation:
Title: ADI-002: an IL-15 armored allogeneic “off-the-shelf” Vδ1 gamma delta CAR T cell therapy for solid tumors targeting glypican-3 (GPC3)
Abstract number: 119
Poster viewing session:
Investor and Media Contacts
Stern Investor Relations, Inc.
Source: Adicet Bio